Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Turner

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Experimental Neurology|September 6, 2003
Biomarkers of Alzheimer's disease and mild cognitive impairment: are we there yet?R Scott Turner
Journal of Geriatric Psychiatry and Neurology|December 20, 2002
Idiopathic rapid eye movement sleep behavior disorder is a harbinger of dementia with Lewy bodiesR Scott Turner
Seminars in Neurology|October 19, 2006
Alzheimer's diseaseR Scott Turner
Neurologic Clinics|November 16, 2002
Inherited dementiasPeter Hedera, R Scott Turner
Frontiers in Neurology|April 11, 2022
Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's DiseaseCharles G Withington, R Scott Turner
Experimental Neurology|January 23, 2004
Adaptor protein interactions: modulators of amyloid precursor protein metabolism and Alzheimer's disease risk?Gwendalyn D King, R Scott Turner
Annals of the New York Academy of Sciences|August 18, 2017
Resveratrol for Alzheimer's diseaseChristine Sawda, Charbel Moussa, R Scott Turner
Journal of Neurochemistry|February 6, 2004
X11alpha impairs gamma- but not beta-cleavage of amyloid precursor proteinGwendalyn D King, Kay Cherian, R Scott Turner
Molecular Neurodegeneration|May 13, 2025
Mouse models of Anti-Aβ immunotherapiesPhilip Pikus, R Scott Turner, G William Rebeck
Journal of Neurochemistry|April 16, 2002
ELISA analysis of beta-secretase cleavage of the Swedish amyloid precursor protein in the secretory and endocytic pathwaysMichelle L Steinhilb, R Scott Turner, James R Gaut
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Experimental Neurology|September 6, 2003
Biomarkers of Alzheimer's disease and mild cognitive impairment: are we there yet?R Scott Turner
Journal of Geriatric Psychiatry and Neurology|December 20, 2002
Idiopathic rapid eye movement sleep behavior disorder is a harbinger of dementia with Lewy bodiesR Scott Turner
Seminars in Neurology|October 19, 2006
Alzheimer's diseaseR Scott Turner
Neurologic Clinics|November 16, 2002
Inherited dementiasPeter Hedera, R Scott Turner
Frontiers in Neurology|April 11, 2022
Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's DiseaseCharles G Withington, R Scott Turner
Experimental Neurology|January 23, 2004
Adaptor protein interactions: modulators of amyloid precursor protein metabolism and Alzheimer's disease risk?Gwendalyn D King, R Scott Turner
Annals of the New York Academy of Sciences|August 18, 2017
Resveratrol for Alzheimer's diseaseChristine Sawda, Charbel Moussa, R Scott Turner
Journal of Neurochemistry|February 6, 2004
X11alpha impairs gamma- but not beta-cleavage of amyloid precursor proteinGwendalyn D King, Kay Cherian, R Scott Turner
Molecular Neurodegeneration|May 13, 2025
Mouse models of Anti-Aβ immunotherapiesPhilip Pikus, R Scott Turner, G William Rebeck
Journal of Neurochemistry|April 16, 2002
ELISA analysis of beta-secretase cleavage of the Swedish amyloid precursor protein in the secretory and endocytic pathwaysMichelle L Steinhilb, R Scott Turner, James R Gaut
Pageof 7